David Rosmarin, MD: Futuristic Therapies for Atopic Dermatitis

David Rosmarin, MD, chair of the department of dermatology at Indiana University School of Medicine, discussed ‘Futuristic therapies for atopic dermatitis’ at the Revolutionizing Atopic Dermatitis (RAD) 2024 Annual Meeting in Chicago.
Rosmarin spoke about the fact that recent advances in understanding the pathogenesis of atopic dermatitis have led to new treatments, yet there continue to be unmet needs for patients with eczema.
“I think what's most important for clinicians is just to be aware of these treatments that are in the process of development, because unfortunately, some of them will not make it,” Rosmarin told HCPLive. “But some of them might. And to understand the pathogenesis of the disease, now that we know more information about it, we can really help target different aspects of the pathway to bring into some of these treatments.”
Link to article: www.hcplive.co...
For additionally dermatology content, please visit our website: www.hcplive.co...
#dermatology #atopicdermatitis